Circulating lymphangiogenic factors in preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Vascular Biology
• Pathophysiology of Pregnancy

Background:

• Preeclampsia (PE) is a pregnancy disorder marked by an anti-angiogenic state.
• The role of lymphangiogenesis in PE has not been previously investigated.
• Impaired vascular endothelial growth factor C (VEGF-C) signaling is linked to edema and hypertension.

Purpose of the Study:

• To investigate circulating levels of VEGF-C and its receptors (sVEGFR-2, sVEGFR-3) in preeclampsia.
• To determine if these levels correlate with PE severity.
• To explore the role of lymphangiogenesis in PE pathogenesis.

Main Methods:

• Plasma levels of VEGF-C, sVEGFR-1, sVEGFR-2, and sVEGFR-3 were measured.
• Analysis was conducted in third-trimester pregnant women with PE (n=20), gestational hypertension (GHTN, n=20), and normotensive pregnancies (NP, n=20).

Main Results:

• sVEGFR-1 levels were significantly higher in PE compared to GHTN and NP.
• VEGF-C levels were higher in PE compared to GHTN, but not NP.
• sVEGFR-3 levels were significantly lower in PE compared to NP.
• The ratio of sVEGFR-2 + sVEGFR-3/VEGF-C was significantly lower in PE compared to GHTN and NP.

Conclusions:

• PE is characterized by a pro-lymphangiogenic state, evidenced by decreased sVEGFR-3, slightly decreased sVEGFR-2, increased VEGF-C, and a lower sVEGFR-2 + sVEGFR-3/VEGF-C ratio.
• This pro-lymphangiogenic state may be a compensatory mechanism for edema and hypertension in PE.
• Further research is needed to clarify the clinical significance of altered lymphangiogenic signaling in PE.